AXSOME THERAPEUTICS INC (AXSM) Stock Earnings Estimates
NASDAQ:AXSM • US05464T1043
163.89 USD
+0.7 (+0.43%)
At close: Feb 27, 2026
163.89 USD
0 (0%)
After Hours: 2/27/2026, 8:00:02 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 270.6M 440.77% | 385.693M 42.53% | 638.496M 65.55% | 1.028B 61.00% | 1.587B 54.38% | 2.063B 29.99% | 2.703B 31.02% | 3.156B 16.76% | 3.243B 2.76% | 3.49B 7.62% | 3.63B 4.01% | |
| EBITDA YoY % growth | -224.991M -28.64% | -272.604M -21.16% | -159.998M 41.31% | 72.69M 145.43% | 458.63M 530.94% | 745.11M 62.46% | 1.174B 57.56% | 1.122B -4.43% | 1.354B 20.68% | 1.551B 14.55% | 1.732B 11.67% | |
| EBIT YoY % growth | -231.825M -29.29% | -280.562M -21.02% | -169.062M 39.74% | 65.91M 138.99% | 467.03M 608.59% | 852.04M 82.44% | 1.44B 69.01% | 1.818B 26.25% | 1.846B 1.54% | 1.945B 5.36% | 2.08B 6.94% | |
| Operating Margin | -85.67% | -72.74% | -26.48% | 6.41% | 29.43% | 41.30% | 53.27% | 57.60% | 56.92% | 55.73% | 57.30% | |
| EPS YoY % growth | -5.20 -13.79% | -5.99 -15.19% | -3.69 38.40% | 0.82 122.19% | 9.16 1,018.12% | 12.64 38.05% | 20.49 62.13% | 26.27 28.16% | 25.12 -4.36% | 26.81 6.74% | 26.63 -0.70% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.65 47.13% | -0.17 82.58% | 0.39 141.29% | 1.14 303.07% | 1.60 348.28% | 2.36 1,494.34% | 3.10 698.95% | 3.94 246.23% |
| Revenue Q2Q % growth | 195.81M 61.21% | 231.08M 54.01% | 273M 59.66% | 320.63M 63.59% | 367.7M 87.78% | 428.93M 85.62% | 486.54M 78.22% | 549.6M 71.41% |
| EBITDA Q2Q % growth | -40.219M 29.63% | -11.837M 63.39% | 20.502M 152.14% | 27.407M 253.17% | 92.198M 329.24% | 116.74M 1,086.22% | 139.4M 579.93% | 176.98M 545.75% |
| EBIT Q2Q % growth | -34.263M 42.20% | -8.939M 75.65% | 29.831M 164.70% | 74.975M 378.13% | 92.198M 369.09% | 116.74M 1,405.95% | 139.4M 367.30% | 176.98M 136.05% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | -0.56 63.64% | -0.68 | 0.12 | 17.97% |
| Q3 2025 Q2Q % growth | -0.94 29.85% | -0.88 | -0.06 | -6.47% |
| Q2 2025 Q2Q % growth | -0.97 41.92% | -1.12 | 0.15 | 13.31% |
| Q1 2025 Q2Q % growth | -1.22 15.28% | -1.35 | 0.13 | 9.80% |
| Q4 2024 Q2Q % growth | -1.54 25.96% | -1.04 | -0.50 | -48.67% |
| Q3 2024 Q2Q % growth | -1.34 -1.52% | -1.44 | 0.10 | 6.83% |
| Q2 2024 Q2Q % growth | -1.67 -8.44% | -1.36 | -0.31 | -22.89% |
| Q1 2024 Q2Q % growth | -1.44 -453.85% | -1.23 | -0.21 | -17.22% |
| Q4 2023 Q2Q % growth | -2.08 -47.52% | -1.19 | -0.89 | -74.11% |
| Q3 2023 Q2Q % growth | -1.32 -23.36% | -1.23 | -0.09 | -7.52% |
| Q2 2023 Q2Q % growth | -1.54 -45.28% | -1.25 | -0.29 | -23.51% |
| Q1 2023 Q2Q % growth | -0.26 74.76% | -1.06 | 0.80 | 75.39% |
| Q4 2022 Q2Q % growth | -1.41 -56.67% | -1.16 | -0.25 | -21.43% |
| Q3 2022 Q2Q % growth | -1.07 -15.05% | -1.10 | 0.03 | 2.80% |
| Q2 2022 Q2Q % growth | -1.06 -23.26% | -1.23 | 0.17 | 13.97% |
| Q1 2022 Q2Q % growth | -1.03 -32.05% | -1.02 | -0.01 | -0.75% |
| Q4 2021 Q2Q % growth | -0.90 -15.38% | -1.04 | 0.14 | 13.63% |
| Q3 2021 Q2Q % growth | -0.93 -60.34% | -0.97 | 0.04 | 4.06% |
| Q2 2021 Q2Q % growth | -0.86 -75.51% | -0.98 | 0.12 | 12.63% |
| Q1 2021 Q2Q % growth | -0.78 11.36% | -0.88 | 0.10 | 11.84% |
| Q4 2020 Q2Q % growth | -0.78 | -0.77 | -0.01 | -0.90% |
| Q3 2020 Q2Q % growth | -0.58 | -0.58 | 0.00 | 0.62% |
| Q2 2020 Q2Q % growth | -0.49 | -0.63 | 0.14 | 22.07% |
| Q1 2020 Q2Q % growth | -0.88 | -0.64 | -0.24 | -38.16% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 195.999M 65.03% | 196.97M | -971K | -0.49% |
| Q3 2025 Q2Q % growth | 170.992M 63.22% | 165.8M | 5.192M | 3.13% |
| Q2 2025 Q2Q % growth | 150.042M 72.13% | 141.54M | 8.502M | 6.01% |
| Q1 2025 Q2Q % growth | 121.463M 61.95% | 122.26M | -797K | -0.65% |
| Q4 2024 Q2Q % growth | 118.766M 66.03% | 120M | -1.234M | -1.03% |
| Q3 2024 Q2Q % growth | 104.762M 81.27% | 100.94M | 3.822M | 3.79% |
| Q2 2024 Q2Q % growth | 87.166M 89.42% | 88.66M | -1.494M | -1.69% |
| Q1 2024 Q2Q % growth | 74.999M -20.70% | 74.761M | 238K | 0.32% |
| Q4 2023 Q2Q % growth | 71.531M 193.52% | 68.915M | 2.616M | 3.80% |
| Q3 2023 Q2Q % growth | 57.794M 242.99% | 55.959M | 1.835M | 3.28% |
| Q2 2023 Q2Q % growth | 46.017M 421.73% | 41.753M | 4.264M | 10.21% |
| Q1 2023 Q2Q % growth | 94.576M | 26.591M | 67.985M | 255.67% |
| Q4 2022 Q2Q % growth | 24.37M | 22.195M | 2.175M | 9.80% |
| Q3 2022 Q2Q % growth | 16.85M | 16.968M | -118K | -0.70% |
| Q2 2022 Q2Q % growth | 8.82M | 6.418M | 2.402M | 37.43% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.65% | 1.64% | 0.26% | -1.71% |
| Revenue | 0.47% | 0.44% | 0.69% | 5.44% |